At the time of writing, Tandem Diabetes Care Inc [TNDM] stock is trading at $12.57, down -5.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TNDM shares have gain 2.44% over the last week, with a monthly amount glided 17.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tandem Diabetes Care Inc [NASDAQ: TNDM] stock has seen the most recent analyst activity on September 08, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $22. Previously, Citigroup upgraded its rating to Neutral on August 12, 2025, and kept the price target unchanged to $10.35. On August 07, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $14 on the stock. Citigroup downgraded its rating to a Sell but stick to its price target of $14 on July 09, 2025. Truist initiated its recommendation with a Hold and recommended $24 as its price target on June 16, 2025. Mizuho started tracking with a Neutral rating for this stock on April 10, 2025, and assigned it a price target of $20. In a note dated March 05, 2025, Morgan Stanley downgraded an Equal-Weight rating on this stock and revised its target price from $45 to $22.
For the past year, the stock price of Tandem Diabetes Care Inc fluctuated between $9.98 and $47.60. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. Tandem Diabetes Care Inc [NASDAQ: TNDM] shares were valued at $12.57 at the most recent close of the market. An investor can expect a potential return of 59.11% based on the average TNDM price forecast.
Analyzing the TNDM fundamentals
According to Tandem Diabetes Care Inc [NASDAQ:TNDM], the company’s sales were 1.00B for trailing twelve months, which represents an 8.46% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.18%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -1.04 and Total Capital is -0.32. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Tandem Diabetes Care Inc [NASDAQ:TNDM] has a current ratio of 2.44. Further, the Quick Ratio stands at 1.88, while the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 0.85, the price to book ratio is 6.37.
Transactions by insiders
Recent insider trading involved Sheridan John F, PRESIDENT & CEO, that happened on Aug 11 ’25 when 10000.0 shares were purchased. EVP & CHIEF FINANCIAL OFFICER, Vosseller Leigh completed a deal on Aug 08 ’25 to buy 13720.0 shares. Meanwhile, EVP & Chief Operating Officer Kyrillos Jean-Claude bought 10538.0 shares on Mar 07 ’25.
